Adamantane and azabicyclo-octane and nonane derivatives, process of their preparation and their use as DPPIV inhibitors

Details for Australian Patent Application No. 2004268832 (hide)

Owner Sanofi-Aventis

Inventors Bata, Imre; Susan, Edit; Urban-Szabo, Katalin; Aranyi, Peter; Boronkay, Eva; Batori, Sandor; Szabo, Tibor; Kapui, Zoltan; Bovy, Philippe; Varga, Marton

Agent Watermark

Pub. Number AU-B-2004268832

PCT Pub. Number WO2005/021536

Priority P0302788 29.08.03 HU

Filing date 27 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 28 April 2011

International Classifications

C07D 207/16 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 215/38 (2006.01) Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 221/22 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups

C07D 231/38 (2006.01) Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings

C07D 241/20 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

C07D 253/06 (2006.01) Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 261/14 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 277/42 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 409/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 451/02 (2006.01) Heterocyclic compounds containing condensed hetero ring systems

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/021536 Priority application(s): WO2005/021536

28 April 2011 Application Accepted

  Published as AU-B-2004268832

25 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268839-Phenyl or pyridyl amide compounds as prostaglandin E2 antagonists

2004268820-Pyrimidothiophene compounds